Product Information
Registration Status: ActiveSIN05856P
DBL POTASSIUM DIHYDROGEN PHOSPHATE CONCENTRATED INJECTION is approved to be sold in Singapore with effective from 1991-05-21. It is marketed by HOSPIRA SINGAPORE PTE LTD, with the registration number of SIN05856P.
This product contains Potassium Phosphate Monobasic (Potassium Dihydrogen Phosphate) 1.361 g in the form of INJECTION. It is approved for INTRAVENOUS use.
This product is manufactured by hameln pharmaceuticals GmbH in GERMANY, andHospira Australia Pty Ltd in AUSTRALIA.
It is an Over-the-counter Medicine that can be freely obtained from any retailer
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.